Literature DB >> 24215461

In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.

Takashi Tamura1, Miwa Asahara, Mikachi Yamamoto, Mariko Yamaura, Mitsuru Matsumura, Kazuo Goto, Ali Rezaei-Matehkolaei, Hossein Mirhendi, Miho Makimura, Koichi Makimura.   

Abstract

To investigate the antifungal drug susceptibility of fungi responsible for dermatomycoses, minimum inhibition concentration (MIC) tests were performed in 44 strains of dermatophytes, including Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton tonsurans, Microsporum canis, Microsporum gypseum and Epidermophyton floccosum, with six antifungal drugs (amorolfine, terbinafine, butenafine, ketoconazole, itraconazole and bifonazole) by broth microdilution assay according to Clinical Laboratory Standard Institute protocols. Six possible dermatomycosis-causing non-dermatophytic fungi were also tested. The two major causes of tinea, T. rubrum and T. mentagrophytes, showed significantly different sensitivities to ketoconazole and bifonazole. Clinically derived dermatophytes were sensitive to the six antifungal drugs tested. However, non-dermatophytes, especially Fusarium spp., tended to be resistant to these antifungal drugs. In Trichophyton spp., the MICs of non-azole drugs had narrower distributions than those of azoles. To evaluate the effects of antifungal drug combinations, the fractional inhibitory concentration index was calculated for the combination of amorolfine and itraconazole as representative external and internal drugs for dermatophytes. It was found that this combination had synergistic or additive effects on most dermatophytes, and had no antagonistic effects. The variation in susceptibility of clinically derived fungal isolates indicates that identification of causative fungi is indispensable for appropriately choosing effective antifungal drugs in the early stages of infection. The results of combination assay suggest that multiple drugs with different antifungal mechanisms against growth of dermatophytes should be used to treat refractory dermatomycoses, especially onychomycosis.
© 2013 The Societies and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  Trichophyton mentagrophytes; Trichophyton rubrum; antifungal combination; fractional inhibitory concentration index

Mesh:

Substances:

Year:  2014        PMID: 24215461     DOI: 10.1111/1348-0421.12109

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  17 in total

1.  Distribution of Species of Dermatophyte Among Patients at a Dermatology Centre of Nghean Province, Vietnam, 2015-2016.

Authors:  Ngoc-Anh Do; Thai-Dung Nguyen; Khac-Luc Nguyen; Tran-Anh Le
Journal:  Mycopathologia       Date:  2017-08-22       Impact factor: 2.574

2.  In Vitro Antifungal Activity of Novel Triazole Efinaconazole and Five Comparators against Dermatophyte Isolates.

Authors:  Ali Rezaei-Matehkolaei; Sadegh Khodavaisy; Mohamad Mahdi Alshahni; Takashi Tamura; Kazuo Satoh; Mahdi Abastabar; Gholam Reza Shokoohi; Bahram Ahmadi; Mohammad Kord; Simin Taghipour; Koichi Makimura; Hamid Badali
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

3.  Morpho-Molecular Characterization of Soil Inhabitant Dermatophytes from Ahvaz, Southwest of Iran, a High Occurrence of Microsporum fulvum.

Authors:  Ali Rezaei-Matehkolaei; Abbas Jahangiri; Ali Zarei Mahmoudabadi; Mohammad Javad Najafzadeh; Sadegh Nouripour-Sisakht; Koichi Makimura
Journal:  Mycopathologia       Date:  2017-01-20       Impact factor: 2.574

4.  In Vitro Antifungal Combination of Terbinafine with Itraconazole against Isolates of Trichophyton Species.

Authors:  Anne-Laure Bidaud; Patrick Schwarz; Anuradha Chowdhary; Eric Dannaoui
Journal:  Antimicrob Agents Chemother       Date:  2021-10-11       Impact factor: 5.938

5.  Mechanism of inhibition of estrogen biosynthesis by azole fungicides.

Authors:  Chinaza Egbuta; Jessica Lo; Debashis Ghosh
Journal:  Endocrinology       Date:  2014-09-22       Impact factor: 4.736

6.  Epidemiological status of dermatophytosis in Guilan, north of Iran.

Authors:  A A Fallahi; A Rezaei-Matehkolaei; S Rezaei
Journal:  Curr Med Mycol       Date:  2017-03

Review 7.  N-Propargylamines: versatile building blocks in the construction of thiazole cores.

Authors:  S Arshadi; E Vessally; L Edjlali; R Hosseinzadeh-Khanmiri; E Ghorbani-Kalhor
Journal:  Beilstein J Org Chem       Date:  2017-03-30       Impact factor: 2.883

8.  Checkerboard Analysis To Evaluate Synergistic Combinations of Existing Antifungal Drugs and Propylene Glycol Monocaprylate in Isolates from Recalcitrant Tinea Corporis and Cruris Patients Harboring Squalene Epoxidase Gene Mutation.

Authors:  Kabir Sardana; Aastha Gupta; Suresh Sadhasivam; R K Gautam; Ananta Khurana; Swamini Saini; Swati Gupta; Shamik Ghosh
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

9.  Melanins Protect Sporothrix brasiliensis and Sporothrix schenckii from the Antifungal Effects of Terbinafine.

Authors:  Rodrigo Almeida-Paes; Maria Helena Galdino Figueiredo-Carvalho; Fábio Brito-Santos; Fernando Almeida-Silva; Manoel Marques Evangelista Oliveira; Rosely Maria Zancopé-Oliveira
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

10.  Molecular Identification and Antifungal Susceptibility Patterns of Clinical Dermatophytes Following CLSI and EUCAST Guidelines.

Authors:  Yubhisha Dabas; Immaculata Xess; Gagandeep Singh; Mragnayani Pandey; Suneeta Meena
Journal:  J Fungi (Basel)       Date:  2017-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.